Regulatory Considerations for Gene Therapy-Specific Companion Diagnostic Devices
Time: 2:15 pm
day: Day 2 REGULATORY PM
Details:
- FDA oversight of in vitro diagnostic devices, including companion diagnostics (CDx)
- Importance of Co-development of a CDx and planning for contemporaneous approval
- Overcoming challenges associated with CDx development
